Empagliflozin, an SGLT2 Inhibitor, Reduced the Mortality Rate after Acute Myocardial Infarction with Modification of Cardiac Metabolomes and Antioxidants in Diabetic Rats
| Image |  |
|---|---|
| Description | scientific article published on 14 December 2018 |
| Author/s |
author: Atsushi Kuno |
| Publication date | December 14, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |